Utilizing biomarkers to support biopsy decision-making

Panelists discuss how biomarkers like IsoPSA can play a key role in biopsy decision-making, particularly when patients express uncertainty or hesitation. By providing objective risk data, IsoPSA offers reassurance for both clinicians and patients considering whether to proceed with invasive testing.

Panelists discuss how incorporating biomarker results into counseling allows for more personalized discussions. Patients at low risk can confidently defer biopsy, while those at higher risk gain clearer justification for moving forward with further evaluation.

Panelists discuss how this approach enhances shared decision-making, reduces patient anxiety, and supports evidence-based recommendations. Biomarkers thus become valuable tools in patient-centered care and communication.